ETON 8-K 2026-11-02

Eton Pharmaceuticals, Inc. (ETON) 8-K dated 2026-11-02 — accession 0001437749-26-034277.

Eton Pharmaceuticals, Inc. (ETON) is a drug manufacturers - specialty & generic company listed on US.

Eton Pharmaceuticals, Inc. filed a 8-K on 2026-11-02. Accession 0001437749-26-034277.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ETON revenue for 2025-12-31 was $80.0M. Net income was -$4.6M. Revenue was up 104.9% from 2024-12-31 to 2025-12-31. ETON currently screens at market cap $797.9M.

Not investment advice. The ETON SEC hub lists recent forms. The stock page is the research view.